QSAM Biosciences Announces FDA Clearance of IND for
Austin, TX, Aug. 25, 2021 (GLOBE NEWSWIRE) - QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear drugs, including samarium-153 DOTMP (CycloSam®), for the treatment of cancer and related drugs Art Diseases…